Skip to main content

Prominent Journals Endorse Standards for Microarray Experiments

BOSTON, Oct. 3 - The Nature journals and The Lancet have publicly endorsed data standards for microarray experiments proposed by the Microarray Gene Expression Data Society, a member of the society said at TIGR's GSAC meeting here today.

The journals said last week they will make the Minimum Information About a Microarray Experiment, or MIAME, a standard requirement for authors submitting microarray data for publication, according to Alvis Brazma, head of the microarray informatics group at the European Bioinformatics Institute.

 

The Nature journals, Brazma added, will also require submission of microarray data to a public database. Moreover, the journal Cell has expressed an interest in following the standards, he said.

The endorsement comes in response to an open letter with guidelines that the MGED recently sent to scientific journals that asked them to "help authors meet" the MIAME data standards. Authors should either provide the required data on a supplementary website or submit the data to one of the public repositories, like the EBI's ArrayExpress or the NCBI's GEO, the letter states.

Brazma also mentioned today that ArrayExpress had just installed on its website the first full version of MIAMExpress, an online submission tool for microarray data.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.